Stella Diagnostics, Inc. (SLDX)
OTCMKTS
· Delayed Price · Currency is USD
0.0490
+0.0090 (22.50%)
At close: Apr 4, 2025
Stella Diagnostics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
19.68M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| American Oncology Network | 1.76B |
Stella Diagnostics News
- 3 years ago - Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference - GlobeNewsWire
- 3 years ago - Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer - GlobeNewsWire
- 3 years ago - Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 3 years ago - Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting - GlobeNewsWire
- 3 years ago - Stella Diagnostics Named ‘Best Clinical Proteomics Solution' of 2021 by Biotech Breakthrough Awards - GlobeNewsWire
- 3 years ago - Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com - GlobeNewsWire